EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fibrocalculous Pancreatic Diabetes (FCPD): A Rare Type of Pancreatogenic Diabetes

Ega Caesaria Pratama Putra, Eva Niamuzisilawati, Yulia Sekarsari, Brilliant Van Fitof Songso Rhomado, Supriyanto Kartodarsono

‎ InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes · 01.12.2025 · 2 (2) · 82-86

DOI: 10.66266/inajemd.v2i2.68 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ‎ InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes, online erschienen am 01.12.2025. Verfasst von Ega Caesaria Pratama Putra und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

FCPD is a rare form of secondary diabetes. FCPD is mainly found in the tropical region; it is characterized by diabetes, chronic abdominal pain, calcification of the pancreas, and steatorrhea. The Incidence of FCPD is often misdiagnosed with type 2 or type 1 diabetes mellitus. A 46-year-old man came with chief complaints of chronic abdominal pain. Abdominal radiography showed calcification in the pancreas. The patient was malnourished. Abdominal X-ray revealed pancreatic calcification, which was confirmed by an abdominal MSCT scan. C-Peptide decreased with an intermediate degree. The patient was given supportive therapy,and insulin was given to control his diabetes. FCPD is a morphological pancreas change caused by chronic tropical pancreatitis. The aetiology of chronic tropical pancreatitis is unknown. FCPD can be diagnosed by history taking and supporting examinations such as abdominal X-ray examination, ultrasound and abdominal CT Scan. C-peptide was examined to assess the function of pancreatic beta cells. The primary treatment for FCPD is insulin therapy; metformin or Sulfonylureas can be used in the early phase of diabetes. In reducing pain, non-steroidal analgesics are used as an option. The use of pancreatic enzyme supplementation can improve the nutritional status of patients. FCPD is a rare case, occurring mainly in tropical countries and in people who are malnourished. The primary treatment for FCPD is insulin therapy.

Zitieren

APA

Putra, E. C. P., Niamuzisilawati, E., Sekarsari, Y., Rhomado, B. V. F. S., & Kartodarsono, S. (2025). Fibrocalculous Pancreatic Diabetes (FCPD): A Rare Type of Pancreatogenic Diabetes. ‎ InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes, 2(2), 82-86. https://doi.org/10.66266/inajemd.v2i2.68

Vancouver

Putra ECP, Niamuzisilawati E, Sekarsari Y, Rhomado BVFS, Kartodarsono S. Fibrocalculous Pancreatic Diabetes (FCPD): A Rare Type of Pancreatogenic Diabetes. ‎ InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes. 2025;2(2):82-86. doi:10.66266/inajemd.v2i2.68

BibTeX
@article{Putra2025,
  author = {Putra, Ega Caesaria Pratama and Niamuzisilawati, Eva and Sekarsari, Yulia and Rhomado, Brilliant Van Fitof Songso and Kartodarsono, Supriyanto},
  title = {Fibrocalculous Pancreatic Diabetes (FCPD): A Rare Type of Pancreatogenic Diabetes},
  journal = {‎ InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes},
  year = {2025},
  volume = {2},
  number = {2},
  pages = {82--86},
  doi = {10.66266/inajemd.v2i2.68}
}
Kostenlos starten →